Phunware
http://www.google.com/search?q=Roth+Capital+initiates+coverage+on+Phunware+with+a+%27Buy%27+rating+and+%242.50+price+target&source=hp&ei=ZO6iYMexE4m5kwXXmauICA&iflsig=AINFCbYAAAAAYKL8dF6U7dAJklk7rTEpr9aDOLCrHZI_&oq=Roth+Capital+initiates+coverage+on+Phunware+with+a+%27Buy%27+rating+and+%242.50+price+target&gs_lcp=Cgdnd3Mtd2l6EANQphRYphRgpRdoAHAAeACAAQCIAQCSAQCYAQCgAQKgAQGqAQdnd3Mtd2l6&sclient=gws-wiz&ved=0ahUKEwjH88iQ4tHwAhWJ3KQKHdfMCoEQ4dUDCAg&uact=5
http://www.google.com/search?q=Phunware+is+redefining+the+way+Fortune+500+brands+engage+with+the+public+on+mobile&source=hp&ei=Pe6iYOqECYrisAfk84CwBg&iflsig=AINFCbYAAAAAYKL8TTaJMl0CFYZiyvN7Lkoxq5KZYRry&oq=Phunware+is+redefining+the+way+Fortune+500+brands+engage+with+the+public+on+mobile&gs_lcp=Cgdnd3Mtd2l6EANQjgtYjgtgvQ9oAHAAeACAAWqIAWqSAQMwLjGYAQCgAQKgAQGqAQdnd3Mtd2l6&sclient=gws-wiz&ved=0ahUKEwiql_L94dHwAhUKMewKHeQ5AGYQ4dUDCAg&uact=5
- Forums
- ASX - General
- Research Reports
Research Reports, page-1187
Featured News
Featured News
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online